Breast Cancer Screening Program in Morocco: Status of implementation, organization and performance

International Journal of Cancer. Journal International Du Cancer
Partha BasuYoussef Chami Khazraji

Abstract

Breast Cancer Screening Program was introduced and rolled out in Morocco in 2010. Women between 40 and 69 years are screened at the primary health centers (PHC) with clinical breast examination (CBE). A comprehensive evaluation of the program was conducted in 2016-2017 for quality assurance and mid-term course correction. The evaluation process involved: in-depth interviews of program managers; focus group discussions with service-providers of screening, diagnosis and treatment; supportive supervisory visits to randomly selected PHCs and diagnostic centers; desk review of the national guidelines and other published documents; and analysis of the performance data compiled by the program-in-charge. We found that the program has strong political support, a well-organized management structure and documented national policy and protocol. In absence of a mechanism to identify and invite the eligible women individually, the program is opportunistic in nature. Every PHC is provided with an annual target to be screened. A highly visible annual campaign to educate and motivate women has a major impact on participation. Record keeping and data collection are paper-based. In the years 2015 and 2016, 1.1 and 1.5 million women were screened,...Continue Reading

References

Jun 1, 1989·Journal of Epidemiology and Community Health·J Whitehead, J Cooper
Jun 22, 2000·Journal of the National Cancer Institute·C J Baines
Sep 11, 2008·Journal of the National Cancer Institute·Quirine Lamberts OkonkwoHarry J de Koning
Aug 22, 2009·International Journal of Cancer. Journal International Du Cancer·Indraneel MittraSurendra S Shastri
Jun 30, 2011·Preventive Medicine·Indraneel Mittra
Aug 25, 2011·Journal of the National Cancer Institute·Rengaswamy SankaranarayananBeela Sara Mathew
Feb 1, 2012·The Breast : Official Journal of the European Society of Mastology·Marilys CorbexHélène Sancho-Garnier
Jul 4, 2012·International Journal of Cancer. Journal International Du Cancer·Freddie BrayJacques Ferlay
Mar 15, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J FerlayF Bray
Feb 27, 2014·The Pan African Medical Journal·Zineb BouchbikaAbdellatif Benider
Oct 6, 2015·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Farida SelmouniRengaswamy Sankaranarayanan
Oct 6, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Samira El FakirChakib Nejjari
Feb 8, 2018·The Lancet Oncology·Farida SelmouniRengaswamy Sankaranarayanan

❮ Previous
Next ❯

Citations

Oct 26, 2018·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·Ranajit Mandal, Partha Basu
Aug 6, 2019·American Journal of Industrial Medicine·Mohamed KhalisBarbara Charbotel
Feb 4, 2021·International Journal of Cancer. Journal International Du Cancer·Patricia VillainUNKNOWN IARC COVID-19 Impact Study Group
May 29, 2021·Journal of Cancer Education : the Official Journal of the American Association for Cancer Education·Mohamed KhalisChakib Nejjari
Jul 20, 2021·The Breast : Official Journal of the European Society of Mastology·Hind MrabtiPartha Basu

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
biopsies

Software Mentioned

Stata

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.